Glucose control before, during, and after orthotropic heart transplantation presents unique challenges. The presence of advanced heart failure contradicts the use of oral metformin and thiozolidinediones (TZDs). The benefit of insulin has been questioned, and recent investigations question the degree of glycemic control in the ICU.1 Scant published data report on the efficacy of oral hypoglycemics on graft function and survival. The purpose of this summary is to present our approach to patients either listed for or undergoing heart transplantation at The Methodist Hospital.

" /> Glucose control before, during, and after orthotropic heart transplantation presents unique challenges. The presence of advanced heart failure contradicts the use of oral metformin and thiozolidinediones (TZDs). The benefit of insulin has been questioned, and recent investigations question the degree of glycemic control in the ICU.1 Scant published data report on the efficacy of oral hypoglycemics on graft function and survival. The purpose of this summary is to present our approach to patients either listed for or undergoing heart transplantation at The Methodist Hospital.

"> Article Full Text – Methodist Journal
Methodist Journal

FEATURED GUEST EDITOR

ISSUE INTRO

The Burgeoning Field of Cardio-Oncology

See More
RECOGNITIONS

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

See More

REVIEW ARTICLES See More

Heart Failure in Relation to Anthracyclines and Other Chemotherapies

Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Cardiovascular Toxicities of Radiation Therapy

Electrophysiologic Complications in Cancer Patients

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?

Future Directions in Cardio-Oncology

CASE REPORTS See More

A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve

Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention

CLINICAL PERSPECTIVES See More

EXCERPTA

Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg

POINTS TO REMEMBER

Onconephrology: An Evolving Field

POINTS TO REMEMBER

Herbal Nephropathy

EXCERPTA

Rolling the Dice on Red Yeast Rice

EDITORIALS

Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 5, Issue 3 (2009)

Article Full Text

REVIEW ARTICLES

Glucose Management, Heart Failure And Transplantation

Jump to:
Article Citation:

Jerry Estep (2009) Percutaneous Device Therapy To Prevent And Treat Acute Decompensated Heart Failure. Methodist DeBakey Cardiovascular Journal: July 2009, Vol. 5, No. 3, pp. 16-25.

doi: https://doi.org/10.14797/mdcj-5-3-12

Abstract

Glucose control before, during, and after orthotropic heart transplantation presents unique challenges. The presence of advanced heart failure contradicts the use of oral metformin and thiozolidinediones (TZDs). The benefit of insulin has been questioned, and recent investigations question the degree of glycemic control in the ICU.1 Scant published data report on the efficacy of oral hypoglycemics on graft function and survival. The purpose of this summary is to present our approach to patients either listed for or undergoing heart transplantation at The Methodist Hospital.

Keywords
glucose , heart transplant , heart failure , insulin , glycemic control

Add Comments

Please login to dialogue with author.

Comments